News
A study by the Evernorth Research Institute looking at national prescription drug use trends found GLP-1 use between 2023-2024 rose 84.6% in Gen Alpha (ages 14 and younger). The age group was ...
Use of GLP-1 Drugs to Treat Overweight or Obesity Increased 587 Percent from 2019 to 2024, According to New FAIR Health Study Provided by PR Newswire May 27, 2025, 12:11:00 PM ...
A separate Prime analysis, however, of year-over-year claims data for Wegovy and Zepbound only found an improvement in ...
But in recent years, the emergence of newer GLP-1 drugs like semaglutide (the active ingredient in Ozempic and Wegovy) has dramatically changed the field of obesity medicine.
In a matched group of more than 170,000 adults, those treated with GLP-1 agonists had a lower risk of developing an obesity-related cancer over a median follow-up of about 4 years when compared ...
When researchers analyzed weight loss results from patients who took GLP-1 drugs and those who'd undergone bariatric surgery, ...
New study shows GLP-1 weight loss drugs can significantly reduce alcohol intake Neurologist Dr. Leah Croll talks about the new research suggesting they might help in treating people with alcohol ...
Of the 102,166 GLP-1s analyzed, 94% had some form of commercial insurance, yet cost-saving options were still widely overlooked.
A follow-up study is in the works to better track why patients stop taking their GLP-1 drugs, researchers said. More information Harvard Medical School has more on GLP-1 drugs .
People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper supervision, and a protein-rich diet, the results of a new study suggest.
People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper supervision, and a protein-rich diet, the results of a new study suggest.
The rising use of glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss is changing how Americans eat, with implications already visible in the food and beverage industry. A new study from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results